Its expression in prostate cancer cells is 100 to 1000 times higher than in normal prostate cells, and its expression levels are associated with prostate specific antigen (PSA) levels, the International Society of Urological Pathology (ISUP) grading, and survival rates12. The gene discussed is KLK3; the disease is prostate carcinoma.